Andrew Mermelstein in Colmar, Pennsylvania

Additional Medical Specialties Include:
INTERNAL MEDICINE

Medical School: New York University School Of Medicine
Graduation Year: 1994
The Primary Medical Specialty for Andrew Mermelstein is listed as: Rheumatology
Approximate Years of Experience: 30
PAC (PECOS ID)#: 5193738318
NPI #: 1215920335
NPI Created On: 08/24/2005
NPI Last Updated Listed as: 11/29/2007
Primary Taxonomy Code: 207RR0500X
License Number:
MD061891L
Listed Gender: Male

---

Forms of insurance accepted by include, but are not limited to:

• AmeriHealth New Jersey
• Blue Cross Blue Shield
• Highmark Health Insurance Company
• AmeriHealth HMO, Inc.
• Highmark Inc.
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: Spanish.

---

Services and Procedures include:

1. Aspiration and/or injection of small joint or joint capsule
2. Aspiration and/or injection of large joint or joint capsule
3. Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour
4. Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
5. Injection of different drug or substance into a vein for therapy, diagnosis, or prevention
6. Non-hormonal anti-neoplastic chemotherapy beneath the skin or into muscle
7. Infusion of chemotherapy into a vein up to 1 hour
8. Infusion of chemotherapy into a vein
9. New patient office or other outpatient visit, typically 30 minutes
10. New patient office or other outpatient visit, typically 45 minutes
11. Established patient office or other outpatient visit, typically 10 minutes
12. Established patient office or other outpatient visit, typically 15 minutes
13. Established patient office or other outpatient, visit typically 25 minutes
14. Physician telephone patient service, 5-10 minutes of medical discussion
15. Physician telephone patient service, 11-20 minutes of medical discussion
16. Physician telephone patient service, 21-30 minutes of medical discussion
17. Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic
18. Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
19. Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
20. Injection, denosumab, 1 mg

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).